Oldest pages
Showing below up to 50 results in range #1,451 to #1,500.
- Creatinine (19:05, 24 May 2024)
- Chronic kidney disease (19:10, 24 May 2024)
- 38. Laboratory diagnosis and monitoring of chronic renal diseases (19:10, 24 May 2024)
- 65. Proteinuria (20:12, 24 May 2024)
- 39. Laboratory findings in proteinuria and haematuria (09:40, 27 May 2024)
- Uric acid (09:49, 27 May 2024)
- 40. Laboratory assessment of increased serum uric acid levels (09:49, 27 May 2024)
- Lumbar puncture (10:03, 27 May 2024)
- Leukocyte (09:52, 28 May 2024)
- Erythrocyte sedimentation rate (09:53, 28 May 2024)
- Liver biochemical tests (09:54, 28 May 2024)
- Pleural effusion (10:15, 28 May 2024)
- 41. Laboratory tests of the cerebrospinal fluid and other body fluids. (10:16, 28 May 2024)
- 16. Neurulation. The structure of the neural tube. Development of the spinal cord (19:51, 28 May 2024)
- 42. Pre-analytical considerations of the hormone tests. (14:56, 30 May 2024)
- 43. Clinical biochemistry of the hypothalamus, hypophysis (14:58, 30 May 2024)
- Hypothyroidism (15:13, 30 May 2024)
- Hashimoto thyroiditis (15:13, 30 May 2024)
- 44. Laboratory assessment of the thyroid function (15:16, 30 May 2024)
- 45. Clinical biochemistry of the disorders of adrenal medulla/cortex (15:16, 30 May 2024)
- Polycystic ovary syndrome (15:23, 30 May 2024)
- B11. Hyperandrogenic disorders, PCOS (15:24, 30 May 2024)
- 37. Laboratory diagnosis of acute renal diseases. (07:09, 18 June 2024)
- B4. Functional diagnostics of the ovarian capacity, cycle diagnostic (10:07, 18 June 2024)
- B12. Infertility; classifications and diagnosis (10:08, 18 June 2024)
- Infertility (female) (10:08, 18 June 2024)
- 46. Clinical biochemistry of the disorders of the human reproductive system (10:09, 18 June 2024)
- 47. The most important non-specific laboratory tests that suggest the presence of malignant diseases. (10:13, 18 June 2024)
- 48. Tumor markers and their informational value in the clinical laboratory practice (11:02, 18 June 2024)
- 49. Molecular biology applications in the practice of clinical laboratories (11:05, 18 June 2024)
- Therapeutic drug monitoring (11:07, 18 June 2024)
- 50. Therapeutic drug monitoring (TDM) (11:07, 18 June 2024)
- 51. Toxicology tests in the clinical laboratory (11:09, 18 June 2024)
- Psoriasis (11:29, 18 June 2024)
- A1. Psoriasis (11:30, 18 June 2024)
- Cellulitis (11:34, 18 June 2024)
- Impetigo (11:34, 18 June 2024)
- Erysipelas (11:37, 18 June 2024)
- Necrotising soft tissue infection (11:38, 18 June 2024)
- Folliculitis (11:39, 18 June 2024)
- Furuncle and carbuncle (11:40, 18 June 2024)
- A2. Pyodermas (11:42, 18 June 2024)
- A3. Basal cell carcinoma and squamous cell carcinoma (11:46, 18 June 2024)
- Atopic dermatitis (11:46, 18 June 2024)
- A4. Atopic dermatitis (11:47, 18 June 2024)
- 4. Interpretation of laboratory results. Biological and analytical factors influencing the results. (16:12, 20 June 2024)
- 1. Postmortem emphysema of the liver (13:53, 21 June 2024)
- 2. Anaemic infarct of the heart (16:35, 27 June 2024)
- 43. Aneurysma thrombotisatum ventriculi sinistri cordis (16:46, 27 June 2024)
- 13. Cholelithiasis, chronic cholecystitis and empyema (16:54, 27 June 2024)